Anaheim Ducks forward Ryan Kesler underwent successful hip surgery on May 9 but is "unlikely" to play next season.
The hip resurfacing surgery leaves open the possibility that Kesler could resume his NHL career following a lengthy recovery. Hip resurfacing is a bone-preserving hip replacement that provides pain relief and increases function in normal activities of daily living.
“As we all know, Ryan has been fiercely battling his condition for quite some time,” said executive vice-president/general manager Bob Murray in a statement. “I’ve been extremely impressed by his determination to play despite being significantly injured. At this point, Ryan needs to think about his life and family. The pain he felt was significant and we agree with his decision to have this surgery.
"While it’s unlikely he will play in 2019-20, we will support any decision he makes about his future playing career. He deserves the utmost respect, which he will receive from the entire Ducks organization as he contemplates his future.”
Kesler won the Selke Trophy as the league's best defensive forward in 2010-11 with the Vancouver Canucks, when he recorded 41 goals and 73 points. Kesler has been a Selke finalist four other times, and in total has 573 career points in 1,001 games.
The 35-year-old last had hip surgery in June 2017 to remove bone fragments.
“At this point in my career, this surgery was the best option for my quality of life,” said Kesler. “The pain I was suffering has been greatly reduced since the procedure, and I’m grateful for that. While my playing future is unknown, I’m in a good place. I want to thank all the doctors and trainers as part of ‘Team Kesler,’ my teammates, my agent Kurt Overhardt, the Ducks organization, the fans, and most importantly, my family, for their support. I’m extremely appreciative of everyone who has helped me through the process. I look forward to spending more time with my family and doing everyday activities without pain.”
Kesler has three years left on his contract with a cap hit of $6.875 million.